ABOS - Acumen Pharmaceuticals GAAP EPS of -$0.25
2024-05-14 07:01:38 ET
More on Acumen Pharmaceuticals
- Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript
- Acumen Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Acumen Pharmaceuticals partners with Lonza to advance sabirnetug for the treatment of Alzheimer’s
- Seeking Alpha’s Quant Rating on Acumen Pharmaceuticals
- Historical earnings data for Acumen Pharmaceuticals